Search research articles
Contact Us
Filters
Showing results (201-210 of 223) with videos related to
Page
of 23
Sort By:
Targeted Oncology
|
February 14, 2019
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
Maja J A de Jonge, Neeltje Steeghs, Martijn P Lolkema, et al.
Cancers
|
March 11, 2023
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data
Sophie H A E Derks, Joost L M Jongen, Edgar L van der Meer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Neuro-Oncology Advances
|
March 7, 2025
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitors
Sophie H A E Derks, Li Shen Ho, Stephan R Koene, et al.
Investigational New Drugs
|
November 1, 2019
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1)
Ruud van der Noll, Agnes Jager, Joo Ern Ang, et al.
Investigational New Drugs
|
January 10, 2018
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
Diane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, et al.
Investigational New Drugs
|
October 23, 2019
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)
Ruud van der Noll, Agnes Jager, Joo Ern Ang, et al.
Obesity Surgery
|
August 17, 2024
Post-Bariatric Hypoglycemia: an Impaired Metabolic Response to a Meal
Ömrüm Aydin, Abraham S Meijnikman, Patrick A de Jonge, et al.
The Oncologist
|
September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study
Floris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
British Journal of Cancer
|
April 17, 2014
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours
N A G Lankheet, J S L Kloth, C G M Gadellaa-van Hooijdonk, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 223) with videos related to
Sort By:
Page
of 23
Targeted Oncology
|
February 14, 2019
Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
Maja J A de Jonge, Neeltje Steeghs, Martijn P Lolkema, et al.
Cancers
|
March 11, 2023
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data
Sophie H A E Derks, Joost L M Jongen, Edgar L van der Meer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2021
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, et al.
Neuro-Oncology Advances
|
March 7, 2025
Size matters: Early progression of melanoma brain metastases after treatment with immune checkpoint inhibitors
Sophie H A E Derks, Li Shen Ho, Stephan R Koene, et al.
Investigational New Drugs
|
November 1, 2019
Phase I study of continuous olaparib capsule dosing in combination with carboplatin and/or paclitaxel (Part 1)
Ruud van der Noll, Agnes Jager, Joo Ern Ang, et al.
Investigational New Drugs
|
January 10, 2018
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer
Diane A J van der Biessen, Jourik A Gietema, Maja J A de Jonge, et al.
Investigational New Drugs
|
October 23, 2019
Phase I study of intermittent olaparib capsule or tablet dosing in combination with carboplatin and paclitaxel (part 2)
Ruud van der Noll, Agnes Jager, Joo Ern Ang, et al.
Obesity Surgery
|
August 17, 2024
Post-Bariatric Hypoglycemia: an Impaired Metabolic Response to a Meal
Ömrüm Aydin, Abraham S Meijnikman, Patrick A de Jonge, et al.
The Oncologist
|
September 5, 2006
Prophylaxis of irinotecan-induced diarrhea with neomycin and potential role for UGT1A1*28 genotype screening: a double-blind, randomized, placebo-controlled study
Floris A de Jong, Diederik F S Kehrer, Ron H J Mathijssen, et al.
British Journal of Cancer
|
April 17, 2014
Pharmacokinetically guided sunitinib dosing: a feasibility study in patients with advanced solid tumours
N A G Lankheet, J S L Kloth, C G M Gadellaa-van Hooijdonk, et al.
Page
of 23